Addison Capital’s Medtronic MDT Stock Holding History

Addison Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,639	Closed	-$206K	–	138
2021 Q3	$206K	Hold	1,639	–	–	0.1%	118
2021 Q2	$204K	Buy	+1,639	New	+$206K	0.1%	113

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Addison Capital's MDT Position: Q4 2021 in Review

Addison Capital sold out of Medtronic (MDT) in Q4 2021, closing a stake of 1,639 shares — an estimated $206K sold.

Addison Capital first reported a position in MDT in Q2 2021 and held it in 2 quarters. The position peaked at $206K in Q3 2021. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

Addison Capital reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
Addison Capital sold 1,639 Medtronic shares in Q4 2021, an estimated $206K.
Addison Capital first reported a position in Medtronic in Q2 2021 and held it in 2 quarters.
Addison Capital's Medtronic position peaked at $206K in Q3 2021.
2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Addison Capital's 13F filing for Q4 2021, filed 18 Jan 2022.